(Bloomberg) -- Patients taking Eli Lilly & Co.’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a ...

With the discovery of insulin at the University of Toronto in the early 1920’s, followed by the establishment of commercial production, diabetes was no longer a ... Grinding pancreases for insulin at ...

After leading diabetes and obesity drug discovery for 10 years at Merck, Moller moved to Lilly in 2006 because of the opportunity to broaden his therapeutic area experience to include ...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus ... Jardiance is propping up Boehringer’s balance sheets, generating annual sales of more than ...